Clinical Trial Update: Cardiac Safe Transplants for Systemic Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for a cardiac-safe transplant approach in systemic sclerosis/scleroderma completed phases 2 and 3; status terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scleroderma
• Systemic Sclerosis

Snippet

Sponsor: Northwestern University | Conditions: Systemic Sclerosis, Scleroderma | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2020-08-12